NDC 0409-4777-11 - CIPROFLOXACIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-4777
- Requested NDC
- 0409-4777-11
- Package NDCs from labels
- 0409-4777-21, 0409-4777-02, 0409-4777-11, 0409-4777-23, 0409-4777-50
- Manufacturer
- Hospira, Inc. | ICU MEDICAL INC.
- Effective date
- 2022-05-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CIPROFLOXACIN - Hospira, Inc. | ICU MEDICAL INC. | Hospira, Inc. | ICU MEDICAL INC. | 2022-05-16 | HUMAN PRESCRIPTION DRUG LABEL |
| CIPROFLOXACIN - Hospira, Inc. | ICU MEDICAL INC. | Hospira, Inc. | ICU MEDICAL INC. | 2020-07-22 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0409-4777-02 | ML - Milliliter | 0409-4777 | 5b31898d-7be5-44b3-a362-5801ffb7e224 | 1 | 2012-07-24 |
| 0409-4777-11 | ML - Milliliter | 0409-4777 | a5471abf-de1e-4a8c-ba2e-c94bdc613d1b | 1 | 2020-04-20 |
| 0409-4777-21 | ML - Milliliter | 0409-4777 | b352eb9d-895a-4bdf-bc90-0f9d3254488f | 1 | 2020-04-20 |
| 0409-4777-23 | ML - Milliliter | 0409-4777 | bd560d5f-9361-4ef0-abbb-afafd372babb | 1 | 2012-07-24 |
| 0409-4777-49 | ML - Milliliter | 0409-4777 | 3a2f13d0-ecab-4622-bcff-615305cb4f9f | 1 | 2012-07-24 |
| 0409-4777-50 | ML - Milliliter | 0409-4777 | 48ce5453-86ef-4938-b3e9-8fad62de0105 | 1 | 2012-07-24 |
| 0409-4777-61 | ML - Milliliter | 0409-4777 | ad478d1d-0884-4476-8c93-8fc9e9519e94 | 1 | 2012-07-24 |
| 0409-4777-62 | ML - Milliliter | 0409-4777 | 2505c855-6f2a-4f29-8c3e-e44b4515f64d | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | fd823bef-c14c-4708-a18a-8aaa8470412f | 2025-11-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 3765c251-eb14-d60f-e063-6294a90a6a4d | 2025-11-12 | Warnings | 059QF0KO0R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37f244fd-c02f-e66a-e063-6394a90aed81 | 2025-11-12 | Warnings | 059QF0KO0R |
| Dextrose in Lactated Ringers | DEXTROSE, SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE | B. Braun Medical Inc. | 190da07e-a616-46e6-b4e5-1c0ba39306e5 | 2025-11-05 | Warnings, Adverse reactions | LX22YL083G |
| Bacteriostatic Water | BACTERIOSTATIC WATER | ProPharma Distribution | 42c6938e-f747-ae13-e063-6294a90a59a3 | 2025-11-04 | Warnings, Adverse reactions | 059QF0KO0R |
| Ciprofloxacin in Dextrose | CIPROFLOXACIN | ProPharma Distribution | 42c758be-4d44-018a-e063-6294a90ae041 | 2025-11-04 | Boxed warning, Warnings, Adverse reactions | 5E8K9I0O4U |
| Ciprofloxacin in Dextrose | CIPROFLOXACIN | Hospira, Inc. | cbbbf939-3219-4515-a48e-ca264daa4d07 | 2025-11-04 | Boxed warning, Warnings, Adverse reactions | 5E8K9I0O4U |
| Dextrose | DEXTROSE MONOHYDRATE | ICU Medical, Inc. | 8b25b7e0-703e-4b43-a4eb-52863511602d | 2025-11-02 | Warnings, Adverse reactions | LX22YL083G |
| Potassium Chloride in Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE | ICU Medical Inc. | d8ee14e9-6733-4813-9f21-2b043a5f7188 | 2025-11-02 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | ICU Medical Inc. | 4555b1bf-6d97-4798-a63d-6d34291c85ce | 2025-11-02 | Warnings, Adverse reactions | LX22YL083G |
| Sterile Water | WATER | ICU Medical Inc. | aab10f03-26ae-4dbc-a481-ef025e48b405 | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | e3484bc6-ed7f-43ef-9d49-c131a8dff2dd | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.